Hubei Hongyuan Pharmaceutical Technology Company Description

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, engages in the production and sale of pharmaceutical products in China and internationally.

It provides active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, triamine, diacetyl guanine, guanine, and diacetylacyclovir; organic chemical raw materials comprising fluoride salts, glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate.

The company was founded in 2002 and is headquartered in Huanggang, China.

Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

Country	China
Founded	2002
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,075
CEO	Shuangxi Xu

Contact Details

Address: No.8 Hongyuan Road Huanggang China
Phone	86 71 3507 2024
Website	hbhypharm.com

Stock Details

Ticker Symbol	301246
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
SIC Code	2834

Key Executives

Name	Position
Shuangxi Xu	Director and General Manager
Kefeng Zeng	Financial Director
Yonghua Xiao	Director
Zhihua Deng	Deputy GM and Non-Independent Director
Siyuan Cheng	Deputy GM and Non-Independent Director